Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis

被引:14
|
作者
Kloosterman, Marielle [1 ]
Oldgren, Jonas [2 ]
Conen, David [3 ]
Wong, Jorge A. [3 ]
Connolly, Stuart J. [3 ]
Avezum, Alvaro [4 ]
Yusuf, Salim [3 ]
Ezekowitz, Michael D. [5 ]
Wallentin, Lars [2 ]
Ntep-Gweth, Marie [6 ]
Joseph, Philip [3 ]
Barrett, Tyler W. [7 ]
Tanosmsup, Supachai [8 ]
McIntyre, William F. [3 ]
Lee, Shun Fu [3 ]
Parkash, Ratika [9 ,10 ]
Amit, Guy [3 ]
Grinvalds, Alex [3 ]
Van Gelder, Isabelle C. [1 ]
Healey, Jeff S. [3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Uppsala Univ, Dept Med Sci, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] McMaster Univ, Populat Hlth Res Inst, Dept Med, 30 Birge St,Room C3-121, Hamilton, ON L8L 0A6, Canada
[4] Dante Pazzanese Inst Cardiol, Div Cardiol, Sao Paulo, Brazil
[5] Med Coll & Lankenau Med Ctr, Dept Med, Wynnewood, PA USA
[6] Hop Cent Yaounde, Dept Med, Yaounde, Cameroon
[7] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[8] Mahidol Univ, Dept Med, Bangkok, Thailand
[9] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Halifax, NS, Canada
[10] Dalhousie Univ, Halifax, NS, Canada
来源
EUROPACE | 2020年 / 22卷 / 06期
关键词
Substrate; Less-established risk factors; Borderline risk factors; Atrial fibrillation hospitalization; Lone atrial fibrillation; Registry; 30-YEAR FOLLOW-UP; MANAGEMENT; COUNTRIES; PROGNOSIS; MORTALITY; DEATH;
D O I
10.1093/europace/euz360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. Methods and results: The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age >= 60years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90mmHg; 47%), chronic kidney disease (eGFR<60mL/min; 57%), obesity (body mass index>30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n=2388), patients without traditional risk factors were more often men (74% vs. 59%, P<0.001) had paroxysmal AF (55% vs. 37%, P<0.001) and less AF persistence after 1 year (21% vs. 49%, P<0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P=0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P<0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P=0.09). Conclusion: Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 50 条
  • [41] Clinical characteristics and outcomes of japanese patients with atrial fibrillation and mitral regurgitation: the fushimi af registry
    Doi, K.
    Iguchi, M.
    Ogawa, H.
    Esato, M.
    Wada, H.
    Hasegawa, K.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 207 - 207
  • [42] COMPARISON OF OUTCOMES FOLLOWING THROMBOLYSIS IN PATIENTS WITH ATRIAL FIBRILLATION (AF) AND WITHOUT AF
    McLoughlin, A.
    Vahidassr, D.
    AGE AND AGEING, 2017, 46
  • [43] Outcomes of patients with atrial fibrillation with and without diabetes: A propensity score matching of the COOL-AF registry
    Krittayaphong, Rungroj
    Aroonsiriwattana, Suchart
    Ngamjanyaporn, Pornchai
    Patmuk, Thanasak
    Kaewkumdee, Pontawee
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [44] Exploration of risk factors for major bleeding in Japanese patients with atrial fibrillation: The Fushimi AF Registry
    Ishii, M.
    Ogawa, H.
    Masunaga, N.
    Iguchi, M.
    Esato, M.
    Chun, Y. H.
    Wada, H.
    Hasegawa, K.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 809 - 809
  • [45] Risk Factors for Intracranial Hemorrhage and Extracranial Hemorrhage in Patients With Atrial Fibrillation: The Fushimi AF Registry
    Ishii, Mitsuru
    Ogawa, Hisashi
    Masunaga, Nobutoyo
    Iguchi, Moritake
    An, Yoshimori
    Esato, Masahiro
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Akao, Masaharu
    CIRCULATION, 2018, 138
  • [46] Comparison of Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation: Results from the RE-LY Trial
    Darius, Harald
    Clemens, Andreas
    Healey, Jeff S.
    Avezum, Alvaro
    Nagarakanti, Rangadham
    Chin, Ashley
    Noack, Herbert
    Connolly, Stuart
    CIRCULATION, 2012, 126 (21)
  • [47] Reduced Cerebral Bleeding Rates with Dabigatran Compared to Warfarin in Patients with Atrial Fibrillation: Results of RE-LY
    Diener, Hans-Christoph
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Pogue, Janice
    Wallentin, Lars
    Reilly, Paul A.
    Yusuf, Salim
    NEUROLOGY, 2010, 74 (09) : A281 - A281
  • [48] Recurrent Events and Mortality Among Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the RE-LY Trial
    Diener, H. C.
    Marijon, E.
    Le Heuzey, J. -Y.
    Connolly, S.
    Noack, H.
    Brueckmann, M.
    Eikelboom, J.
    Ezekowitz, M.
    Clemens, A.
    Reilly, P.
    Wallentin, L.
    Yusuf, S.
    CEREBROVASCULAR DISEASES, 2013, 35 : 165 - 165
  • [49] Dabigatran Versus Warfarin in Very Elderly Patients with Atrial Fibrillation: Results from the RE-LY Trial
    Coppens, Michiel
    Eikelboom, John
    Ezekowitz, Michael
    Clemens, Andreas
    Healy, Jeff
    Wallentin, Lars
    Noack, Herbert
    Yusuf, Salim
    Connolly, Stuart
    CIRCULATION, 2012, 126 (21)
  • [50] Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial
    Brambatti, Michela
    Darius, Harald
    Oldgren, Jonas
    Clemens, Andreas
    Noack, Herbert H.
    Brueckmann, Martina
    Yusuf, Salim
    Wallentin, Lars
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Healey, Jeff S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 196 : 127 - 131